JPWO2019157597A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019157597A5 JPWO2019157597A5 JP2020543276A JP2020543276A JPWO2019157597A5 JP WO2019157597 A5 JPWO2019157597 A5 JP WO2019157597A5 JP 2020543276 A JP2020543276 A JP 2020543276A JP 2020543276 A JP2020543276 A JP 2020543276A JP WO2019157597 A5 JPWO2019157597 A5 JP WO2019157597A5
- Authority
- JP
- Japan
- Prior art keywords
- cell
- cells
- notch ligand
- floating
- stem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023191915A JP2024016217A (ja) | 2018-02-14 | 2023-11-10 | Ｔ細胞系列の細胞を発生させるための方法 |
| JP2025216743A JP2026031647A (ja) | 2018-02-14 | 2025-12-02 | Ｔ細胞系列の細胞を発生させるための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862630497P | 2018-02-14 | 2018-02-14 | |
| US62/630,497 | 2018-02-14 | ||
| PCT/CA2019/050181 WO2019157597A1 (en) | 2018-02-14 | 2019-02-14 | Method for generating cells of the t cell lineage |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023191915A Division JP2024016217A (ja) | 2018-02-14 | 2023-11-10 | Ｔ細胞系列の細胞を発生させるための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021514185A JP2021514185A (ja) | 2021-06-10 |
| JPWO2019157597A5 true JPWO2019157597A5 (https=) | 2022-02-10 |
| JP2021514185A5 JP2021514185A5 (https=) | 2022-02-10 |
Family
ID=67619677
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020543276A Pending JP2021514185A (ja) | 2018-02-14 | 2019-02-14 | Ｔ細胞系列の細胞を発生させるための方法 |
| JP2023191915A Pending JP2024016217A (ja) | 2018-02-14 | 2023-11-10 | Ｔ細胞系列の細胞を発生させるための方法 |
| JP2025216743A Pending JP2026031647A (ja) | 2018-02-14 | 2025-12-02 | Ｔ細胞系列の細胞を発生させるための方法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023191915A Pending JP2024016217A (ja) | 2018-02-14 | 2023-11-10 | Ｔ細胞系列の細胞を発生させるための方法 |
| JP2025216743A Pending JP2026031647A (ja) | 2018-02-14 | 2025-12-02 | Ｔ細胞系列の細胞を発生させるための方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12467034B2 (https=) |
| EP (1) | EP3752602A4 (https=) |
| JP (3) | JP2021514185A (https=) |
| KR (1) | KR20200121817A (https=) |
| CN (1) | CN112041431A (https=) |
| AU (2) | AU2019220935B2 (https=) |
| CA (1) | CA3091158A1 (https=) |
| WO (1) | WO2019157597A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021514185A (ja) | 2018-02-14 | 2021-06-10 | サニーブルック リサーチ インスティチュート | Ｔ細胞系列の細胞を発生させるための方法 |
| JP2023548115A (ja) * | 2020-10-28 | 2023-11-15 | サンガモ セラピューティクス， インコーポレイテッド | ヒト多能性幹細胞からのｃｄ４＋エフェクターおよび制御性ｔ細胞の生成 |
| WO2022115492A1 (en) * | 2020-11-24 | 2022-06-02 | Lyell Immunopharma, Inc. | Methods for making, compositions comprising, and methods of using rejuvenated t cells |
| US11661459B2 (en) | 2020-12-03 | 2023-05-30 | Century Therapeutics, Inc. | Artificial cell death polypeptide for chimeric antigen receptor and uses thereof |
| AU2021392032A1 (en) | 2020-12-03 | 2023-06-22 | Century Therapeutics, Inc. | Genetically engineered cells and uses thereof |
| KR20230128324A (ko) * | 2021-02-05 | 2023-09-04 | 고쿠리츠다이가쿠호진 고베다이가쿠 | 인공 다능성 줄기 세포 유래 γδ T 세포 및 그 제작방법 |
| WO2022216524A1 (en) | 2021-04-07 | 2022-10-13 | Century Therapeutics, Inc. | Combined artificial cell death/reporter system polypeptide for chimeric antigen receptor cell and uses thereof |
| CA3210702A1 (en) | 2021-04-07 | 2022-10-13 | Century Therapeutics, Inc. | Gene transfer vectors and methods of engineering cells |
| WO2022241558A1 (en) * | 2021-05-18 | 2022-11-24 | The University Of British Columbia | A method for producing blood progenitor and progenitor t cells, resulting cells and methods and uses thereof |
| WO2023129937A1 (en) | 2021-12-29 | 2023-07-06 | Century Therapeutics, Inc. | Genetically engineered cells having anti-cd19 / anti-cd22 chimeric antigen receptors, and uses thereof |
| IL314801A (en) | 2022-02-22 | 2024-10-01 | Juno Therapeutics Inc | Proteinase 3 (PR3) Chimeric Autoantigen Receptor T Cells and Related Methods and Uses |
| CN119365492A (zh) | 2022-05-04 | 2025-01-24 | 世纪治疗股份有限公司 | 用hla-e和hla-g转基因工程化的细胞 |
| JP2025522360A (ja) | 2022-06-08 | 2025-07-15 | センチュリー セラピューティクス，インコーポレイテッド | Ｃｄ１６変異体およびｎｋｇ２ｄを発現する遺伝子操作した細胞ならびにその使用 |
| CA3257650A1 (en) | 2022-06-08 | 2023-12-14 | Century Therapeutics, Inc. | Immunoeffector cells derived from genetically modified, multipotential stem cells with membrane IL-12 and their uses |
| WO2023240212A2 (en) | 2022-06-08 | 2023-12-14 | Century Therapeutics, Inc. | Genetically engineered cells having anti-cd133 / anti-egfr chimeric antigen receptors, and uses thereof |
| WO2024102838A1 (en) | 2022-11-09 | 2024-05-16 | Century Therapeutics, Inc. | Engineered interleukin-7 receptors and uses thereof |
| KR20250143301A (ko) | 2022-11-10 | 2025-10-01 | 센츄리 쎄라퓨틱스 인코포레이티드 | 항-넥틴4 키메라 항원 수용체를 갖는 유전자 조작 세포 및 이의 용도 |
| WO2024156066A1 (en) * | 2023-01-27 | 2024-08-02 | Notch Therapeutics (Canada), Inc. | Method for generating t cell lineage populations from stem/progenitor cells |
| WO2025101938A2 (en) | 2023-11-10 | 2025-05-15 | Century Therapeutics, Inc. | Genetically engineered cells having multi-transmembrane domain chimeric antigen receptors utilizing g protein-coupled receptor scaffolds, and uses thereof |
| WO2025106626A1 (en) | 2023-11-15 | 2025-05-22 | Century Therapeutics, Inc. | Genetically engineered cells expressing c-x-c chemokine receptor type 4, and uses thereof |
| WO2025207798A1 (en) | 2024-03-26 | 2025-10-02 | Century Therapeutics, Inc. | Genetically engineered cells having anti-cd123 chimeric antigen receptors, and uses thereof |
| WO2025207795A1 (en) | 2024-03-26 | 2025-10-02 | Juno Therapeutics, Inc. | Genetically engineered cells having anti-cd33 / anti-cd123 chimeric antigen receptors, and uses thereof |
| US20250332260A1 (en) | 2024-04-10 | 2025-10-30 | Garuda Therapeutics, Inc. | Immune compatible cells for allogeneic cell therapies to cover global, ethnic, or disease-specific populations |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100895231B1 (ko) | 2002-03-25 | 2009-05-04 | 다카라 바이오 가부시키가이샤 | 세포상해성 림프구의 제조방법 |
| JP2006506322A (ja) | 2002-04-05 | 2006-02-23 | ロランティス リミテッド | 内科療法 |
| US7575925B2 (en) * | 2002-12-10 | 2009-08-18 | Sunnybrook Health Sciences Centre | Cell preparations comprising cells of the T cell lineage and methods of making and using them |
| JP2006517533A (ja) * | 2003-01-23 | 2006-07-27 | ロランティス リミテッド | Ｎｏｔｃｈシグナル伝達経路のアクチベーターを用いる自己免疫疾患の治療 |
| WO2007027226A2 (en) * | 2005-04-28 | 2007-03-08 | Board Of Regents, The University Of Texas System | Systems and methods for the production of differentiated cells |
| EP2321407A4 (en) | 2008-09-11 | 2012-07-18 | Univ Florida | SYSTEM AND METHOD FOR THE PRODUCTION OF T-CELLS |
| JP5756017B2 (ja) * | 2008-11-07 | 2015-07-29 | サニーブルック ヘルス サイエンシズ センター | ヒト前駆ｔ細胞 |
| US8871510B2 (en) | 2009-12-03 | 2014-10-28 | University Of Utah Research Foundation | Methods for generating T lymphocytes from hematopoietic stem cells |
| ES2608937T3 (es) | 2010-02-22 | 2017-04-17 | Université Pierre Et Marie Curie (Paris 6) | Medio de cultivo celular para el crecimiento y diferenciación de células del linaje hematopoyético |
| CN104053769A (zh) * | 2011-11-21 | 2014-09-17 | 大学健康网络 | 造血祖细胞群体和富集其干细胞的方法 |
| US10180254B2 (en) * | 2014-09-16 | 2019-01-15 | Hitachi Zosen Inova Ag | Method and device for processing slag occurring in a combustion chamber of a refuse incineration plant |
| FR3026744B1 (fr) * | 2014-10-06 | 2024-04-19 | Hopitaux Paris Assist Publique | Methode de generation de progeniteurs de cellules t |
| AU2016211671B2 (en) | 2015-01-26 | 2022-05-26 | Fate Therapeutics, Inc. | Methods and compositions for inducing hematopoietic cell differentiation |
| WO2016187459A1 (en) | 2015-05-20 | 2016-11-24 | The Regents Of The University Of California | Method for generating human dendritic cells for immunotherapy |
| JP7049261B2 (ja) * | 2016-04-08 | 2022-04-06 | ザ ガバニング カウンシル オブ ザ ユニバーシティ オブ トロント | 幹細胞および／または前駆細胞からｔ前駆細胞を作製する方法ならびに該ｔ前駆細胞の使用 |
| US20190134169A1 (en) | 2016-04-26 | 2019-05-09 | Temple University-Of The Commonwealth System Of Higher Education | DLL4-expressing cells and vaccine using the same |
| IL268641B2 (en) | 2017-02-13 | 2024-10-01 | Assist Publique Hopitaux Paris Aphp | Method for generating t cells progenitors |
| JP2021514185A (ja) | 2018-02-14 | 2021-06-10 | サニーブルック リサーチ インスティチュート | Ｔ細胞系列の細胞を発生させるための方法 |
| EP4326856A4 (en) * | 2021-04-23 | 2025-10-08 | Sunnybrook Res Inst | STEM CELLS COMPRISING AN UNREARRANGED T CELL RECEPTOR (TCR) GENE LOCUS AND METHODS OF USE THEREOF |
| WO2022241558A1 (en) * | 2021-05-18 | 2022-11-24 | The University Of British Columbia | A method for producing blood progenitor and progenitor t cells, resulting cells and methods and uses thereof |
-
2019
- 2019-02-14 JP JP2020543276A patent/JP2021514185A/ja active Pending
- 2019-02-14 KR KR1020207024814A patent/KR20200121817A/ko not_active Ceased
- 2019-02-14 US US16/969,854 patent/US12467034B2/en active Active
- 2019-02-14 CA CA3091158A patent/CA3091158A1/en active Pending
- 2019-02-14 WO PCT/CA2019/050181 patent/WO2019157597A1/en not_active Ceased
- 2019-02-14 AU AU2019220935A patent/AU2019220935B2/en active Active
- 2019-02-14 EP EP19754265.7A patent/EP3752602A4/en active Pending
- 2019-02-14 CN CN201980025370.1A patent/CN112041431A/zh active Pending
-
2023
- 2023-11-10 JP JP2023191915A patent/JP2024016217A/ja active Pending
-
2025
- 2025-06-17 AU AU2025204516A patent/AU2025204516A1/en active Pending
- 2025-10-20 US US19/363,170 patent/US20260043003A1/en active Pending
- 2025-12-02 JP JP2025216743A patent/JP2026031647A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2019157597A5 (https=) | ||
| JP2021514185A5 (https=) | ||
| Salem et al. | Mesenchymal stromal cells: current understanding and clinical status | |
| Nombela-Arrieta et al. | The elusive nature and function of mesenchymal stem cells | |
| Elahi et al. | Human mesenchymal stromal cells from different sources diverge in their expression of cell surface proteins and display distinct differentiation patterns | |
| Arcangeli et al. | Function of Jam-B/Jam-C interaction in homing and mobilization of human and mouse hematopoietic stem and progenitor cells | |
| Martin et al. | Efficient thymic immigration of B220+ lymphoid-restricted bone marrow cells with T precursor potential | |
| Robinson et al. | Human peripheral blood contains two distinct lineages of dendritic cells | |
| Mabuchi et al. | Prospective isolation of murine and human bone marrow mesenchymal stem cells based on surface markers | |
| Young et al. | Retention of quiescent hematopoietic cells with high proliferative potential during ex vivo stem cell culture | |
| McGuckin et al. | Multiparametric analysis of immature cell populations in umbilical cord blood and bone marrow | |
| Attar | Changes in the cell surface markers during normal hematopoiesis: a guide to cell isolation | |
| Signore et al. | Identity and ranking of colonic mesenchymal stromal cells | |
| JP2008518603A5 (https=) | ||
| Oberlin et al. | VE-cadherin expression allows identification of a new class of hematopoietic stem cells within human embryonic liver | |
| JP2012509666A5 (https=) | ||
| Colvin et al. | Intrinsic hematopoietic stem cell/progenitor plasticity: Inversions | |
| CN109486763A (zh) | 外周血来源的树突状细胞培养方法 | |
| Freund et al. | Comparative analysis of proliferative potential and clonogenicity of MACS‐immunomagnetic isolated CD34+ and CD133+ blood stem cells derived from a single donor | |
| Almeida-Porada et al. | Evaluation of serum-free culture conditions able to support the ex vivo expansion and engraftment of human hematopoietic stem cells in the human-to-sheep xenograft model | |
| JP2005204539A5 (https=) | ||
| O’Neill et al. | Skeletal stem/progenitor cells provide the niche for extramedullary hematopoiesis in spleen | |
| Andrade et al. | Initial CD34+ cell‐enrichment of cord blood determines hematopoietic stem/progenitor cell yield upon ex vivo expansion | |
| Milazzo et al. | Cord blood CD 34+ cells expanded on W harton's jelly multipotent mesenchymal stromal cells improve the hematopoietic engraftment in NOD/SCID mice | |
| JPWO2020243613A5 (https=) |